Competitive endogenous network of circRNA, lncRNA, and miRNA in osteosarcoma chemoresistance

Osteosarcoma is the most prevalent and fatal type of bone tumor. Despite advancements in the treatment of other cancers, overall survival rates for patients with osteosarcoma have stagnated over the past four decades Multiple-drug resistance—the capacity of cancer cells to become simultaneously resi...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Shuang, Wang, Yuting, Ma, Chunhui, Lv, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504747/
https://www.ncbi.nlm.nih.gov/pubmed/37717007
http://dx.doi.org/10.1186/s40001-023-01309-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504747/
https://www.ncbi.nlm.nih.gov/pubmed/37717007
http://dx.doi.org/10.1186/s40001-023-01309-x

Ejemplares similares